Dr. Dana Matthews, MD – Seattle, WA
T cells from three hemophilia A subjects recognized the same HLA-restricted FVIII epitope with a narrow TCR repertoire
Ettinger, RA, Paz P, James EA, Gunasekera D, Aswad F, Thompson AR, Matthews DC, Pratt KP, Blood, 1/1/2016Personalized Approaches to Therapies for Hemophilia (PATH) Study Investigators Factor VIII gene variants and inhibitor risk in African American hemophilia A patients
Gunasekera D, Ettinger RA, Nakaya Fletcher S, James EA, Liu M, Barrett JC, Withycombe J, Matthews DC, Epstein MS, Hughes RJ, Pratt KP, Blood, 1/1/2015Eltrombopag for the treatment of children with persistent and chronic immune thrombocytopenia (PETIT): a randomized, multicenter, placebo-controlled study
Bussel JB, Garcia de Miguel P, Despotovic JM, Grainger JD, Sevilla J, Blanchette VS, Krishnamurti L, Connor P, David M, Boayue KB, Matthews DC, Lambert MP, Marcello LM..., The Lancet Haematology, 1/1/2015
